How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/tonsillitis-due-to-streptococcus-pyogenes.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Tonsillitis due to Streptococcus Pyogenes — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tonsillitis due to Streptococcus Pyogenes (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Tonsillitis due to Streptococcus Pyogenes, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Ketek	TELITHROMYCIN	Sanofi	Ketolide Antibacterial	Potassium voltage-gated channel subfamily H member 2		2004-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Sanofi · 1 drug in Tonsillitis due to Streptococcus Pyogenes

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Tonsillitis due to Streptococcus Pyogenes:

Cite this brief

Drug Landscape (2026). Tonsillitis due to Streptococcus Pyogenes — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/tonsillitis-due-to-streptococcus-pyogenes. Accessed 2026-06-10.

Tonsillitis due to Streptococcus Pyogenes full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing